APA (7th ed.) Citation

Yu, T., Jin, X., Yu, F., Yang, X., Zeng, Y., Meng, T., . . . Hu, F. (2022). Tumor and dendritic cell dual-targeting nanocarriers maximize the therapeutic potential of IDO1 inhibitor in vivo. Nano research, 15(10), 9204-9214. https://doi.org/10.1007/s12274-022-4597-7

Chicago Style (17th ed.) Citation

Yu, Tong, Xiangyu Jin, Fangying Yu, Xiqin Yang, Yingping Zeng, Tingting Meng, Hong Yuan, and Fuqiang Hu. "Tumor and Dendritic Cell Dual-targeting Nanocarriers Maximize the Therapeutic Potential of IDO1 Inhibitor in Vivo." Nano Research 15, no. 10 (2022): 9204-9214. https://doi.org/10.1007/s12274-022-4597-7.

MLA (9th ed.) Citation

Yu, Tong, et al. "Tumor and Dendritic Cell Dual-targeting Nanocarriers Maximize the Therapeutic Potential of IDO1 Inhibitor in Vivo." Nano Research, vol. 15, no. 10, 2022, pp. 9204-9214, https://doi.org/10.1007/s12274-022-4597-7.